AKBA
Akebia Therapeutics Inc.
$2.79
+$0.04(+1.45%)
34
Overall
20
Value
40
Tech
42
Quality
Market Cap
$782.18M
Volume
1.89M
52W Range
$1.30 - $4.08
Target Price
$7.40
EPS Estimates Overview
| Current Quarter | $-0.01 | Next Quarter | $0.02 |
| Current Year | $0.03 | Next Year | $0.23 |
| QoQ Growth | +300.0% | YoY Growth | +666.7% |
| 3Y EPS CAGR | +42.1% | Target Price | $7.40 |
| Consensus | Buy | Upside | +165.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $2.79 | +1.5% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW